| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.60B | $1.58B | $1.54B |
| YoY Revenue Growth % | +0.8% | +2.6% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $448.4M | $463.8M | $375.0M |
| Operating Margin % | 28.1% | 29.3% | 24.3% |
| Net Income (GAAP) | $369.9M | $299.7M | $258.5M |
| EBITDA (Normalized) | $505.9M | $520.8M | $430.6M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $270.4M | $319.4M | $296.6M |
| Capital Expenditures (CapEx) | $71.9M | $71.3M | $69.5M |
| Free Cash Flow (FCF) | $198.6M | $248.1M | $227.1M |
| FCF Margin % | 12.4% | 15.7% | 14.7% |
| Return on Invested Capital (ROIC %) | 17.3% | 21.8% | 17.5% |
| Cash & Short-Term Equivalents | $45.0M | $40.2M | — |
| Total Debt (Short + Long Term) | $1.91B | $1.77B | $656.9M |
| Total Stockholders' Equity | $181.2M | -$45.3M | $1.35B |